Sothema

China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced a significant licensing and commercialization agreement with Sothema, the leading pharmaceutical company in Morocco, for its biosimilar version of AbbVie’s (NYSE: ABBV) Humira (adalimumab). According to the agreement, Sothema will handle local filling finish, registration, and commercialization of the biosimilar…